BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, ...

FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...

BD Diagnostics, a segment of Becton, Dickinson and Co., has announced it has received FDA clearance for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor system for ...

December 19, 2011 — A new rapid test for diagnosing influenza types A and B — the first to offer a digital readout of results — has been granted a Clinical Laboratory Improvement Amendments (CLIA) ...

New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global ...